Decentralized Clinical Trials

Decentralized clinical trials, or DCTs, looked to be a slow-moving trend for much of the 2010s. Here and there, certain aspects would appear in trials, be it healthcare wearables, virtual site visits, or remote patient monitoring. Suddenly, the onset of the global pandemic forced the pharma industry’s hand, resulting in an overnight conversion of all […]

Collecting accurate, reliable data in clinical trials once meant trial visits. Patients diligently taking the medication or intervention would trek to the nearest trial center to undergo a battery of tests before being shuttled home. But as decentralized clinical trials (DCTs) sweep through clinical and pharmaceutical research, there’s a new data collection method in town:

The rapid adoption of decentralized clinical trials (DCTs), also known as remote clinical trials, has revolutionized pharmaceutical research and the approach taken by clinical operations teams in conducting their clinical trials. While such changes began prior to the pandemic, COVID-19 accelerated this trend, allowing clinical research and drug development to continue in an era of